D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 47 Citations 10,883 148 World Ranking 3464 National Ranking 1579

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Virus

Kenneth E. Ugen mainly focuses on Immunology, Virology, Immune system, DNA vaccination and Virus. His Immunology study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Genetically modified mouse. Kenneth E. Ugen interconnects Alzheimer's disease and Amyloid in the investigation of issues within Genetically modified mouse.

His Virology study integrates concerns from other disciplines, such as T cell and Cellular immunity, Antigen, Immunogenicity. His work investigates the relationship between Immune system and topics such as DNA that intersect with problems in Host, Attenuated vaccine, Inoculation, Reverse transcriptase and Heterologous. His study in Virus is interdisciplinary in nature, drawing from both Plasmid and Serology.

His most cited work include:

  • Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease (1486 citations)
  • Gene inoculation generates immune responses against human immunodeficiency virus type 1. (681 citations)
  • First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response (550 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Immunology, Virology, Immune system, DNA vaccination and Antibody. His work carried out in the field of Immunology brings together such families of science as Acquired immunodeficiency syndrome and In vivo. His Virology research includes elements of Cellular immunity, Immunization and Immunogenicity.

His Immune system research incorporates elements of Cytotoxic T cell and Cytokine. His studies in DNA vaccination integrate themes in fields like Adjuvant, Viral Vaccine, AIDS Vaccines, Zika virus and Simian immunodeficiency virus. His research integrates issues of Molecular biology and Genetically modified mouse in his study of Antibody.

He most often published in these fields:

  • Immunology (54.66%)
  • Virology (50.31%)
  • Immune system (33.54%)

What were the highlights of his more recent work (between 2012-2020)?

  • DNA vaccination (25.47%)
  • Immunology (54.66%)
  • Virology (50.31%)

In recent papers he was focusing on the following fields of study:

Kenneth E. Ugen mainly focuses on DNA vaccination, Immunology, Virology, Antibody and Immune system. His biological study spans a wide range of topics, including Viral Vaccine, Vaccination, Biotechnology and Immunity. His research in Vaccination intersects with topics in Alzheimer's disease and Immunotherapy.

His Immunology research is multidisciplinary, incorporating perspectives in Genetically modified mouse and Disease. His study in the field of Virus and Transmission is also linked to topics like Middle East respiratory syndrome coronavirus. His Immune system study incorporates themes from Adjuvant and Zika virus.

Between 2012 and 2020, his most popular works were:

  • A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates (157 citations)
  • In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine (101 citations)
  • Anti-Human α-Synuclein N-Terminal Peptide Antibody Protects against Dopaminergic Cell Death and Ameliorates Behavioral Deficits in an AAV-α-Synuclein Rat Model of Parkinson’s Disease (57 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Virus
  • Immune system

His primary areas of investigation include Antibody, Immunology, Virology, Monoclonal antibody and DNA vaccination. His Antibody research is multidisciplinary, incorporating elements of Ex vivo, Genetically modified mouse, Transgene and Dendritic cell, Antigen. Many of his research projects under Immunology are closely connected to NeuN with NeuN, tying the diverse disciplines of science together.

His Virology study combines topics in areas such as Humoral immunity, Immune system and Disease. Within one scientific family, he focuses on topics pertaining to In vivo under Monoclonal antibody, and may sometimes address concerns connected to Immunotherapy, Cell, Antibody-dependent cell-mediated cytotoxicity, Glutamate carboxypeptidase II and Prostate cancer. In his study, Vaccination, Immunity, Immunoglobulin G and Plasmid is inextricably linked to Virus, which falls within the broad field of DNA vaccination.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

Dave Morgan;David M. Diamond;Paul E. Gottschall;Kenneth E. Ugen.
Nature (2000)

2073 Citations

Gene inoculation generates immune responses against human immunodeficiency virus type 1.

Bin Wang;Kenneth E. Ugen;Vasantha Srikantan;Michael G. Agadjanyan.
Proceedings of the National Academy of Sciences of the United States of America (1993)

986 Citations

First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response

Rob Roy MacGregor;Jean D. Boyer;Kenneth E. Ugen;Kim E. Lacy.
The Journal of Infectious Diseases (1998)

775 Citations

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.

Adil I. Daud;Ronald C. DeConti;Stephanie Andrews;Patricia Urbas.
Journal of Clinical Oncology (2008)

756 Citations

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

Jean D. Boyer;Kenneth E. Ugen;Bin Wang;Michael Agadjanyan.
Nature Medicine (1997)

482 Citations

Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation

Donna M. Wilcock;Giovanni DiCarlo;Debbi Henderson;Jennifer Jackson.
The Journal of Neuroscience (2003)

376 Citations

Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration

Donna M Wilcock;Sanjay K Munireddy;Arnon Rosenthal;Kenneth E Ugen.
Neurobiology of Disease (2004)

241 Citations

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

Karuppiah Muthumani;Darryl Falzarano;Emma L. Reuschel;Colleen Tingey.
Science Translational Medicine (2015)

233 Citations

DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates.

Ban Wang;Jean Boyer;Vasantha Srikantan;Leslie Coney.
DNA and Cell Biology (1993)

221 Citations

Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.

Jeong-Im Sin;Jong J. Kim;Kenneth E. Ugen;Richard B. Ciccarelli.
European Journal of Immunology (1998)

165 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kenneth E. Ugen

David B. Weiner

David B. Weiner

The Wistar Institute

Publications: 167

David C. Montefiori

David C. Montefiori

Duke University

Publications: 60

Britta Wahren

Britta Wahren

Karolinska Institute

Publications: 56

Jean D. Boyer

Jean D. Boyer

Inovio Pharmaceuticals (United States)

Publications: 46

Richard Heller

Richard Heller

University of South Florida

Publications: 45

Marie-Pierre Rols

Marie-Pierre Rols

Federal University of Toulouse Midi-Pyrénées

Publications: 43

Damijan Miklavčič

Damijan Miklavčič

University of Ljubljana

Publications: 40

Jeffrey B. Ulmer

Jeffrey B. Ulmer

Novartis (Switzerland)

Publications: 35

Thomas Wisniewski

Thomas Wisniewski

New York University

Publications: 31

Jorma Hinkula

Jorma Hinkula

Linköping University

Publications: 29

George N. Pavlakis

George N. Pavlakis

National Institutes of Health

Publications: 29

James A. R. Nicoll

James A. R. Nicoll

University of Southampton

Publications: 28

Norman L. Letvin

Norman L. Letvin

Beth Israel Deaconess Medical Center

Publications: 28

John W. Shiver

John W. Shiver

United States Military Academy

Publications: 27

Kenji Okuda

Kenji Okuda

Yokohama City University

Publications: 26

Antonin de Fougerolles

Antonin de Fougerolles

Alnylam Pharmaceuticals (United States)

Publications: 26

Trending Scientists

Alistair Sinclair

Alistair Sinclair

University of California, Berkeley

Arne Haug

Arne Haug

Norwegian University of Science and Technology

Antonio J. Ricco

Antonio J. Ricco

Ames Research Center

Harald Fuchs

Harald Fuchs

University of Münster

José Luis Quero

José Luis Quero

University of Córdoba

Anthony W. D'Amato

Anthony W. D'Amato

University of Vermont

Armando Jacinto Aguilar-Caballero

Armando Jacinto Aguilar-Caballero

Autonomous University of Yucatán

Taekjip Ha

Taekjip Ha

Johns Hopkins University

Helle Krogh Johansen

Helle Krogh Johansen

University of Copenhagen

Pedro Terrinha

Pedro Terrinha

Instituto Português do Mar e da Atmosfera

Arnaud Mialon

Arnaud Mialon

Centre national de la recherche scientifique, CNRS

Bradley K. Taylor

Bradley K. Taylor

University of Pittsburgh

Paavo H.T. Leppänen

Paavo H.T. Leppänen

University of Jyväskylä

Rachel K. Clifton

Rachel K. Clifton

University of Massachusetts Amherst

Yoshiki Miyachi

Yoshiki Miyachi

Kyoto University

Andrew Siderowf

Andrew Siderowf

University of Pennsylvania

Something went wrong. Please try again later.